MedTrace Logo

COVID-19 in Patients With Chronic Liver Diseases

NCT04439084 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1025

Last updated 2021-08-09

No results posted yet for this study

Summary

This study seeks to determine how COVID-19 affects the clinical outcome of patients with chronic liver disease, and whether the clinical course of COVID-19 is influenced by underlying chronic liver disease.

Conditions

Interventions

OTHER

Prospective Chart Review

Collected data will include demographic features, clinical characteristics, clinical outcome, medication use, COVID-19-related complications in patients with chronic liver disease.

Sponsors & Collaborators

Principal Investigators

  • Renumathy Dhanasekaran, MD · Stanford University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-06
Primary Completion
2021-07-31
Completion
2021-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04439084 on ClinicalTrials.gov